Hualan Biological: Net profit in 2025 is expected to decrease by 13.55% year-on-year, with a proposed dividend of 5 RMB for every 10 shares.

2026-03-29 01:23:39

On March 27, People’s Financial News reported that Hualan Biological (002007) disclosed its annual report on March 27, achieving an operating income of 4.595 billion yuan in 2025, a year-on-year increase of 4.93%; the net profit attributable to shareholders was 940 million yuan, a year-on-year decrease of 13.55%; basic earnings per share were 0.5151 yuan. The company plans to distribute a cash dividend of 5 yuan (including tax) for every 10 shares to all shareholders. On the same day, Hualan Biological announced that it intends to transfer 75% of its equity in its holding subsidiary Hualan Biological Engineering (Suzhou) Co., Ltd. for a transfer price of 96.7141 million yuan.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes